Long-Term Outcomes of Partial Oral Treatment of Endocarditis

doi:10.1056/NEJMc1902096

. 2019 Apr 4;380(14):1373-1374.

doi: 10.1056/NEJMc1902096. Epub 2019 Mar 17.

Long-Term Outcomes of Partial Oral Treatment of Endocarditis

Henning Bundgaard¹, Nikolaj Ihlemann¹, Sabine U Gill², Niels E Bruun³, Hanne Elming⁴, Trine Madsen⁵, Kaare T Jensen⁶, Kurt Fursted⁷, Jens J Christensen⁸, Martin Schultz³, Lauge Østergaard³, Flemming Rosenvinge², Henrik C Schønheyder⁵, Jannik Helweg-Larsen⁹, Emil L Fosbøll⁹, Lars Køber⁹, Christian Torp-Pedersen⁵, Niels Tønder¹⁰, Claus Moser⁹, Kasper Iversen³

Affiliations

¹ Copenhagen University Hospital, Copenhagen, Denmark henning.bundgaard@regionh.dk.
² Odense University Hospital, Odense, Denmark.
³ Copenhagen University Hospital, Copenhagen, Denmark.
⁴ Zealand University Hospital, Roskilde, Denmark.
⁵ Aalborg University Hospital, Aalborg, Denmark.
⁶ Aarhus University Hospital, Aarhus, Denmark.
⁷ Statens Serum Institut, Copenhagen, Denmark.
⁸ University of Copenhagen, Slagelse, Denmark.
⁹ University of Copenhagen, Copenhagen, Denmark.
¹⁰ University of Copenhagen, Hillerød, Denmark.

PMID: 30883059
DOI: 10.1056/NEJMc1902096

Long-Term Outcomes of Partial Oral Treatment of Endocarditis

Henning Bundgaard et al. N Engl J Med. 2019.

. 2019 Apr 4;380(14):1373-1374.

doi: 10.1056/NEJMc1902096. Epub 2019 Mar 17.

Authors

Affiliations

¹ Copenhagen University Hospital, Copenhagen, Denmark henning.bundgaard@regionh.dk.
² Odense University Hospital, Odense, Denmark.
³ Copenhagen University Hospital, Copenhagen, Denmark.
⁴ Zealand University Hospital, Roskilde, Denmark.
⁵ Aalborg University Hospital, Aalborg, Denmark.
⁶ Aarhus University Hospital, Aarhus, Denmark.
⁷ Statens Serum Institut, Copenhagen, Denmark.
⁸ University of Copenhagen, Slagelse, Denmark.
⁹ University of Copenhagen, Copenhagen, Denmark.
¹⁰ University of Copenhagen, Hillerød, Denmark.

PMID: 30883059
DOI: 10.1056/NEJMc1902096

No abstract available

PubMed Disclaimer

Cited by

Dynamics of a Staphylococcus aureus infective endocarditis simulation model.
Schwartz FA, Nielsen L, Struve Andersen J, Bock M, Christophersen L, Sunnerhagen T, Lerche CJ, Bay L, Bundgaard H, Høiby N, Moser C. Schwartz FA, et al. APMIS. 2022 Aug;130(8):515-523. doi: 10.1111/apm.13231. Epub 2022 May 27. APMIS. 2022. PMID: 35460117 Free PMC article.
Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis.
Schellong P, Joean O, Pletz MW, Hagel S, Weis S. Schellong P, et al. Drugs. 2025 Feb;85(2):193-214. doi: 10.1007/s40265-024-02135-z. Epub 2024 Dec 25. Drugs. 2025. PMID: 39720961 Free PMC article. Review.
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.
Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, Commodore-Mensah Y, Currie ME, Elkind MSV, Fan W, Generoso G, Gibbs BB, Heard DG, Hiremath S, Johansen MC, Kazi DS, Ko D, Leppert MH, Magnani JW, Michos ED, Mussolino ME, Parikh NI, Perman SM, Rezk-Hanna M, Roth GA, Shah NS, Springer MV, St-Onge MP, Thacker EL, Urbut SM, Van Spall HGC, Voeks JH, Whelton SP, Wong ND, Wong SS, Yaffe K, Palaniappan LP; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. Martin SS, et al. Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27. Circulation. 2025. PMID: 39866113 Review.
Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies.
Kouijzer JJP, Noordermeer DJ, van Leeuwen WJ, Verkaik NJ, Lattwein KR. Kouijzer JJP, et al. Front Cell Dev Biol. 2022 Oct 3;10:995508. doi: 10.3389/fcell.2022.995508. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36263017 Free PMC article. Review.
Oral Antibiotics for Bacteremia and Infective Endocarditis: Current Evidence and Future Perspectives.
Eleftheriotis G, Marangos M, Lagadinou M, Bhagani S, Assimakopoulos SF. Eleftheriotis G, et al. Microorganisms. 2023 Dec 18;11(12):3004. doi: 10.3390/microorganisms11123004. Microorganisms. 2023. PMID: 38138148 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Long-Term Outcomes of Partial Oral Treatment of Endocarditis

Affiliations

Long-Term Outcomes of Partial Oral Treatment of Endocarditis

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical